gt_law

The Delaware General Corporation Law (DGCL) has been amended by two pieces of legislation. The first set of amendments, adopted as Senate Substitute 1 to Senate Bill 21, implement significant

Continue Reading Drafting of Corporate and M&A Documents for 2025 Delaware General Corporation Law Amendments

President Trump has introduced a new 10% tariff on Chinese imports effective February 4, 2025, affecting “de minimis” shipments and prohibiting duty drawback refunds, prompting companies to reassess supply chains and import strategies. In retaliation, China has imposed tariffs on U.S. goods, while proposed tariffs on Mexico and Canada are temporarily paused for further negotiation.
Continue Reading Trump Administration Imposes Tariffs on China Imports; Proposes and Then Pauses Tariffs on Mexico and Canada Imports

Michael Schaengold, Melissa Prusock, and Danielle Muenzfeld co-authored an article in The Government Contractor titled “FEATURE COMMENT: The FY 2020 National Defense Authorization Act’s Substantial Impact On Federal
Continue Reading The FY 2020 National Defense Authorization Act’s Substantial Impact On Federal Procurement Law

Advanced Communications Services (ACS) that are available in video games, such as instant messaging, enable players to interact with other players and offer an enhanced gaming experience. The Twenty-First Century
Continue Reading Federal Communications Commission Rules Require Communications in Video Games to Be Accessible and Usable

A newly approved Bill could significantly increase disclosure requirements for Israelis invested in or operating business in the U.S. The Corporate Transparency Act of 2019 would require that the identities
Continue Reading U.S. House Passes Bill That Would Require Disclosure of Beneficial Owners of U.S. Corporations and Limited Liability Companies

The United States Attorney’s Office for the Southern District of Florida announced on Sept. 19, 2019, that it settled a qui tam False Claims Act case in which a private
Continue Reading 2 Recent Cases Impacting False Claims Act Litigation and Investigations Deserve the Attention of Health Care Providers and Private Equity Investors